Showing results 11 - 20 of 123
Gill Jennings & Every LLP has an extensive EPO opposition practice and has long played a leading role in the development of EPO case law. The EPO Board of Appeal has recently issued a rare ‘B...
We are pleased to announce Graham Spenceley has joined the Partnership. Graham re-joined Gill Jennings & Every in 2018, having originally trained at the firm between 2006 and 2011. ...
The UK Supreme Court’s decision in Shanks v Unilever has provided some guidance on the circumstances that may lead to an inventor being entitled to a financial reward from their employer under ...
OncoImmunity AS has been acquired by renowned Japanese IT and network company, NEC Corporate. OncoImmunity AS develops software that identifies neoantigen targets for truly personalized cancer vacci...
We are pleased to announce Matthew Hoyles, Edward Carstairs and John Fisher have joined the partnership. Matthew and Edward have been promoted to partners of the IT & Engineering an...
Read our September 2025 trade mark law and practice update, including updates from the UK, EU China, Canada and US...
Read our August 2025 patent law and practice update, including updates from the UK, the European Patent Office (EPO) and the WIPO/PCT....
Read our July 2025 patent law update, including updates from the UK, the European Patent Office (EPO) and the WIPO/PCT...
In this article, we set out the key aspects for innovators and applicants to consider when patenting gene editors in Europe....
Antibody-drug conjugates (ADCs) are a biotherapeutic modality typically used for the treatment of cancer....